Jonsson Comprehensive Cancer Center
🇺🇸United States
Focal Laser Ablation of Prostate Tissue
Early Phase 1
Completed
- Conditions
- Prostate Cancer
- Interventions
- Device: Focal Laser Ablation
- First Posted Date
- 2015-02-06
- Last Posted Date
- 2020-09-21
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 11
- Registration Number
- NCT02357121
- Locations
- 🇺🇸
University of California Los Angeles, Los Angeles, California, United States
🇺🇸UCLA, Los Angeles, California, United States
Radiation Therapy in Preventing Liver Metastases in Patients With Uveal Melanoma Who HaveMonosomy 3 or DecisionDx Class 2 Disease and Are More Likely to Develop Liver Metastases
Not Applicable
Terminated
- Conditions
- Iris MelanomaStage IIA Uveal MelanomaStage IIIC Uveal MelanomaMedium/Large Size Posterior Uveal MelanomaStage IIB Uveal MelanomaStage IIIB Uveal MelanomaStage IIIA Uveal Melanoma
- Interventions
- Radiation: External Beam Radiation TherapyOther: Laboratory Biomarker Analysis
- First Posted Date
- 2015-01-13
- Last Posted Date
- 2020-07-24
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 2
- Registration Number
- NCT02336763
- Locations
- 🇺🇸
Jonsson Comprehensive Cancer Center, Los Angeles, California, United States
Anti-tumor Immune Response in Patients With Cancer Undergoing Radiation Therapy
Terminated
- Conditions
- Malignant Neoplasm
- Interventions
- Other: cytology specimen collection procedureOther: laboratory biomarker analysis
- First Posted Date
- 2014-12-08
- Last Posted Date
- 2022-08-18
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 139
- Registration Number
- NCT02310594
- Locations
- 🇺🇸
Jonsson Comprehensive Cancer Center, Los Angeles, California, United States
Stereotactic Body Radiation Therapy in Treating Patients With Localized High-Risk Prostate Cancer
Not Applicable
Active, not recruiting
- Conditions
- Adenocarcinoma of the ProstateStage III Prostate Cancer
- Interventions
- Radiation: stereotactic body radiation therapyOther: quality-of-life assessmentOther: laboratory biomarker analysisDrug: androgen deprivation therapy
- First Posted Date
- 2014-11-20
- Last Posted Date
- 2025-02-24
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 220
- Registration Number
- NCT02296229
- Locations
- 🇺🇸
Jonsson Comprehensive Cancer Center, Los Angeles, California, United States
Germ-Line Mutations in Blood and Saliva Samples From Patients With Cancer
Recruiting
- Conditions
- Malignant Neoplasm
- Interventions
- Other: cytology specimen collection procedure
- First Posted Date
- 2014-10-31
- Last Posted Date
- 2024-10-08
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 2000
- Registration Number
- NCT02280161
- Locations
- 🇺🇸
Jonsson Comprehensive Cancer Center, Los Angeles, California, United States
Intermittent LGX818 and MEK162 in Treating Patients With Metastatic Melanoma Who Have BRAFV600 Mutations
Phase 2
Withdrawn
- Conditions
- Recurrent MelanomaStage IV Melanoma
- Interventions
- First Posted Date
- 2014-10-13
- Last Posted Date
- 2020-07-27
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Registration Number
- NCT02263898
- Locations
- 🇺🇸
Jonsson Comprehensive Cancer Center, Los Angeles, California, United States
Predictors of Patient Attitudes and Barriers to Skin Cancer Screening
Completed
- Conditions
- Skin Cancer
- Interventions
- Other: Survey
- First Posted Date
- 2014-09-09
- Last Posted Date
- 2020-07-27
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 1040
- Registration Number
- NCT02235116
- Locations
- 🇺🇸
UCLA Dermatology, Los Angeles, California, United States
Use of Laser Interstitial Thermal Therapy in the Focal Treatment of Localized Prostate Cancer
Completed
- Conditions
- Prostate Cancer
- Interventions
- Device: Laser Interstitial Thermal Therapy
- First Posted Date
- 2014-08-25
- Last Posted Date
- 2020-07-27
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 8
- Registration Number
- NCT02224911
- Locations
- 🇺🇸
UCLA, Los Angeles, California, United States
Low-Fat Diet and Fish Oil in Men on Active Surveillance for Prostate Cancer
Not Applicable
Active, not recruiting
- Conditions
- Adenocarcinoma of the ProstateStage IIB Prostate CancerStage I Prostate CancerStage IIA Prostate Cancer
- Interventions
- Behavioral: behavioral dietary interventionDietary Supplement: omega-3 fatty acidOther: laboratory biomarker analysis
- First Posted Date
- 2014-06-27
- Last Posted Date
- 2025-02-10
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 107
- Registration Number
- NCT02176902
- Locations
- 🇺🇸
Jonsson Comprehensive Cancer Center, Los Angeles, California, United States
68Ga DOTATATE PET/CT in Neuroendocrine Tumors (Expanded Access)
- Conditions
- Carcinoid CancerNeuroendocrine TumorsCancers Expressing Somatostatin ReceptorsMedullary Thyroid Cancer
- First Posted Date
- 2014-06-25
- Last Posted Date
- 2020-07-27
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Registration Number
- NCT02174679
- Locations
- 🇺🇸
UCLA Hospital, Los Angeles, California, United States
© Copyright 2025. All Rights Reserved by MedPath